Logo image of BKN

BLACKROCK INVEST QLTY MUNI (BKN) Stock Overview

USA - NYSE:BKN - US09247D1054

11.36 USD
+0.02 (+0.18%)
Last: 10/1/2025, 1:31:59 PM
Fundamental Rating

2

Taking everything into account, BKN scores 2 out of 10 in our fundamental rating. BKN was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BKN have multiple concerns. BKN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BKN was profitable.
In the past year BKN has reported a negative cash flow from operations.
In multiple years BKN reported negative net income over the last 5 years.
Each year in the past 5 years BKN had a positive operating cash flow.
BKN Yearly Net Income VS EBIT VS OCF VS FCFBKN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Industry RankSector Rank
ROA 2.14%
ROE 2.62%
ROIC 1.86%
ROA(3y)-2.28%
ROA(5y)0.41%
ROE(3y)-2.62%
ROE(5y)0.44%
ROIC(3y)2.12%
ROIC(5y)2.18%
BKN Yearly ROA, ROE, ROICBKN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

In the last couple of years the Profit Margin of BKN has declined.
BKN's Operating Margin has declined in the last couple of years.
BKN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 54.4%
PM (TTM) 49.93%
GM 57.73%
OM growth 3Y-10.65%
OM growth 5Y-3.42%
PM growth 3Y-41.28%
PM growth 5Y-14.3%
GM growth 3Y-10.96%
GM growth 5Y-3.73%
BKN Yearly Profit, Operating, Gross MarginsBKN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

More info and screens

3

2. Health

2.1 Basic Checks

BKN has less shares outstanding than it did 1 year ago.
BKN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BKN has a worse debt to assets ratio.
BKN Yearly Shares OutstandingBKN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BKN Yearly Total Debt VS Total AssetsBKN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 1.88 indicates that BKN is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.21 indicates that BKN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 1.88
ROIC/WACCN/A
WACCN/A
BKN Yearly LT Debt VS Equity VS FCFBKN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

BKN has a Current Ratio of 1.18. This is a normal value and indicates that BKN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.18 indicates that BKN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
BKN Yearly Current Assets VS Current LiabilitesBKN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 588.89% over the past year.
BKN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.91% yearly.
BKN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.98%.
The Revenue has been decreasing by -4.43% on average over the past years.
EPS 1Y (TTM)588.89%
EPS 3Y-44.69%
EPS 5Y-17.91%
EPS Q2Q%-135.29%
Revenue 1Y (TTM)-10.98%
Revenue growth 3Y-6.17%
Revenue growth 5Y-4.43%
Sales Q2Q%1.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BKN Yearly Revenue VS EstimatesBKN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.82, the valuation of BKN can be described as expensive.
When comparing the Price/Earnings ratio of BKN to the average of the S&P500 Index (27.76), we can say BKN is valued inline with the index average.
Industry RankSector Rank
PE 25.82
Fwd PE N/A
BKN Price Earnings VS Forward Price EarningsBKN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKN Per share dataBKN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.55%, BKN is a good candidate for dividend investing.
BKN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 5.55%

5.2 History

The dividend of BKN decreases each year by -3.98%.
BKN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BKN decreased recently.
Dividend Growth(5Y)-3.98%
Div Incr Years1
Div Non Decr Years1
BKN Yearly Dividends per shareBKN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

157.14% of the earnings are spent on dividend by BKN. This is not a sustainable payout ratio.
BKN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP157.14%
EPS Next 2YN/A
EPS Next 3YN/A
BKN Yearly Income VS Free CF VS DividendBKN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
BKN Dividend Payout.BKN Dividend Payout, showing the Payout Ratio.BKN Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK INVEST QLTY MUNI

NYSE:BKN (10/1/2025, 1:31:59 PM)

11.36

+0.02 (+0.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners27.13%
Inst Owner Change4.73%
Ins Owners0%
Ins Owner Change0%
Market Cap195.51M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 5.55%
Yearly Dividend0.56
Dividend Growth(5Y)-3.98%
DP157.14%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-15 2025-09-15 (0.057)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25.82
Fwd PE N/A
P/S 13.03
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)0.44
EY3.87%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS0.87
BVpS16.62
TBVpS16.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.14%
ROE 2.62%
ROCE 2.35%
ROIC 1.86%
ROICexc 1.86%
ROICexgc 1.86%
OM 54.4%
PM (TTM) 49.93%
GM 57.73%
FCFM N/A
ROA(3y)-2.28%
ROA(5y)0.41%
ROE(3y)-2.62%
ROE(5y)0.44%
ROIC(3y)2.12%
ROIC(5y)2.18%
ROICexc(3y)2.13%
ROICexc(5y)2.19%
ROICexgc(3y)2.13%
ROICexgc(5y)2.19%
ROCE(3y)2.69%
ROCE(5y)2.76%
ROICexcg growth 3Y-5.67%
ROICexcg growth 5Y-1.75%
ROICexc growth 3Y-5.67%
ROICexc growth 5Y-1.75%
OM growth 3Y-10.65%
OM growth 5Y-3.42%
PM growth 3Y-41.28%
PM growth 5Y-14.3%
GM growth 3Y-10.96%
GM growth 5Y-3.73%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.77
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.88
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)588.89%
EPS 3Y-44.69%
EPS 5Y-17.91%
EPS Q2Q%-135.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.98%
Revenue growth 3Y-6.17%
Revenue growth 5Y-4.43%
Sales Q2Q%1.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.93%
EBIT growth 3Y-16.17%
EBIT growth 5Y-7.7%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-156.38%
FCF growth 3Y39.81%
FCF growth 5Y111.18%
OCF growth 1Y-156.38%
OCF growth 3Y39.81%
OCF growth 5Y111.18%